KIMBERLY BOWEN: Open Payments
NPI 1275100158 · CAMPBELLSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 34 payments from 8 companies in 2025. Trend: 2023 $290 · 2024 $268 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $181 |
| Vanda Pharmaceuticals Inc. | 11 | $176 |
| Indivior Inc. | 3 | $72 |
| Amgen Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $28 |
| Lilly USA, LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: FANAPT, VRAYLAR, SUBLOCADE, OTEZLA, QULIPTA, Wegovy, JARDIANCE, CAPLYTA.
Industry payments across KY — which companies pay providers there.
